Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe day after a Wegovy injection, most people notice one of three things: mild nausea, some tiredness, or nothing at all. All three are normal. Semaglutide's effects build gradually, and the first 24–48 hours after each dose can feel different depending on where you are in the titration schedule. These are prescription-only medicines that a qualified prescriber assesses individually — so what follows is general education, not a substitute for guidance from your own clinical team.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The most useful thing to decide the morning after an injection is whether what you're feeling is an expected response or something that needs attention. For most people, the day after a dose involves some degree of nausea, reduced appetite, and occasionally loose stools or constipation. These are the hallmarks of GLP-1 receptor activation: the medicine slows gastric emptying and acts on appetite centres in the brain. Your gut is adjusting.
Fatigue is also common. Some people feel a low-level tiredness for 12 to 24 hours after injecting, which often improves once they eat something light and drink enough fluid. Headache is reported too, usually linked to reduced food intake rather than the medicine itself. If you find yourself sipping water more slowly because nausea is making even drinks unappealing, small, frequent sips are easier on the stomach than large glasses.
The broader picture of life after Wegovy includes understanding that these effects tend to ease as your body acclimates to each dose level. Most people find the 24-hour window after each shot gets more manageable over the first month. If yours is getting harder rather than easier, that is worth raising with your prescriber.
The NHS's patient information for semaglutide outlines the full side-effect profile and when to seek further advice.
Systemic symptoms and local reactions are often confused, but they have different causes and different timelines. A small lump under the skin where you injected is usually a subcutaneous tissue response and is not cause for concern in most cases. Redness or tenderness at the site tends to peak in the first few hours and fade within a day or two.
A bruise after the shot is also common, particularly if you inject into an area with more surface blood vessels. It does not indicate that the medicine has been absorbed incorrectly. Rotating your injection sites (abdomen, thigh, upper arm) across doses helps reduce localised irritation. If you always use the same spot, give it a rest for the next injection.
One practical routine detail worth mentioning: the pen lives in your fridge, but some people find keeping a note on the fridge door of which site they used last makes rotation effortless. Small habit, genuinely useful.
If arm pain after a Wegovy shot is more than mild tenderness (if it is spreading, warm to the touch, or accompanied by swelling beyond the injection area) contact your prescriber or GP the same day. Significant skin reactions are listed in the Patient Information Leaflet as requiring medical review.
Most next-day effects are uncomfortable rather than dangerous. But there are symptoms that should prompt you to seek help promptly rather than wait them out. Severe stomach pain that radiates to your back, with or without vomiting, can be a sign of acute pancreatitis. The MHRA issued a Drug Safety Update in January 2026 highlighting pancreatitis as a known but infrequent serious risk with GLP-1 medicines; persistent, severe abdominal pain is the key warning sign. Call 111 or go to A&E if that describes what you are experiencing.
Signs of a serious allergic reaction (widespread rash, difficulty breathing, swelling of the face or throat) need emergency care. Severe dehydration from persistent vomiting or diarrhoea can also become serious quickly; if you cannot keep fluids down for more than a few hours, seek medical advice. You can report any suspected side effect through the MHRA's Yellow Card scheme, which helps regulators monitor these medicines in real-world use.
If you are unsure whether what you are feeling is within the expected range, the nume aftercare team is available seven days a week. We would rather hear from you than have you guessing.
Some people find that choosing their injection day strategically makes the following 24 hours easier to manage. Injecting on a Friday evening, for instance, means any next-day sluggishness falls on a Saturday. That is not a medical recommendation — it is a practical observation from people who have found a rhythm that works for them.
Food choices the day after a dose matter more than on other days. Fatty, rich or large meals are more likely to worsen nausea when gastric emptying is already slowed. Plain, protein-centred meals in smaller portions tend to sit better. Alcohol on the day after a dose is worth avoiding: it can amplify nausea and adds dehydration risk.
For context on how Wegovy fits into the broader cost of private weight-loss treatment, our price comparison page covers what legitimate UK prescriptions typically include and what to look out for. If you are earlier in the process of deciding whether semaglutide is right for you, the semaglutide overview covers the licensed indications, eligibility criteria and the evidence base in full.
If you have not yet started treatment and want a same-day clinical assessment from a GPhC-registered prescriber, check your eligibility with our free consultation.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.